8-K - NRx Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or oth

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated December 18, 2025 99.2 Debt Cancellation Agreement / Pay-Of

Exhibits Only

Source Document

Exhibits (3)

8-K

FORM 8-K

99.1

EXHIBIT 99.1

99.2

EXHIBIT 99.2